19-35295965-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_002361.4(MAG):c.399C>T(p.Ser133Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.239 in 1,590,544 control chromosomes in the GnomAD database, including 48,238 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3910 hom., cov: 32)
Exomes 𝑓: 0.24 ( 44328 hom. )
Consequence
MAG
NM_002361.4 synonymous
NM_002361.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.368
Genes affected
MAG (HGNC:6783): (myelin associated glycoprotein) The protein encoded by this gene is a type I membrane protein and member of the immunoglobulin superfamily. It is thought to be involved in the process of myelination. It is a lectin that binds to sialylated glycoconjugates and mediates certain myelin-neuron cell-cell interactions. Three alternatively spliced transcripts encoding different isoforms have been described for this gene. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 19-35295965-C-T is Benign according to our data. Variant chr19-35295965-C-T is described in ClinVar as [Benign]. Clinvar id is 1168325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.368 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.398 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAG | NM_002361.4 | c.399C>T | p.Ser133Ser | synonymous_variant | Exon 4 of 11 | ENST00000392213.8 | NP_002352.1 | |
MAG | NM_001199216.2 | c.324C>T | p.Ser108Ser | synonymous_variant | Exon 4 of 11 | NP_001186145.1 | ||
MAG | NM_080600.3 | c.399C>T | p.Ser133Ser | synonymous_variant | Exon 4 of 12 | NP_542167.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.213 AC: 32357AN: 152038Hom.: 3901 Cov.: 32
GnomAD3 genomes
AF:
AC:
32357
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.274 AC: 63903AN: 233174Hom.: 9719 AF XY: 0.274 AC XY: 34641AN XY: 126328
GnomAD3 exomes
AF:
AC:
63903
AN:
233174
Hom.:
AF XY:
AC XY:
34641
AN XY:
126328
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.242 AC: 347399AN: 1438388Hom.: 44328 Cov.: 34 AF XY: 0.245 AC XY: 174693AN XY: 712896
GnomAD4 exome
AF:
AC:
347399
AN:
1438388
Hom.:
Cov.:
34
AF XY:
AC XY:
174693
AN XY:
712896
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.213 AC: 32398AN: 152156Hom.: 3910 Cov.: 32 AF XY: 0.219 AC XY: 16286AN XY: 74356
GnomAD4 genome
AF:
AC:
32398
AN:
152156
Hom.:
Cov.:
32
AF XY:
AC XY:
16286
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1300
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 75 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at